Cargando…

Declines in Pneumonia Hospitalizations of Children Aged <2 Years Associated with the Use of Pneumococcal Conjugate Vaccines — Tennessee, 1998–2012

Detalles Bibliográficos
Autores principales:	Griffin, Marie R., Mitchel, Edward, Moore, Matthew R., Whitney, Cynthia G., Grijalva, Carlos G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	U.S. Centers for Disease Control 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860731/ https://www.ncbi.nlm.nih.gov/pubmed/25375070

Ejemplares similares

Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
por: Wiese, Andrew D., et al.
Publicado: (2016)

The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
por: Griffith, Hannah, et al.
Publicado: (2022)

Progress in Introduction of Pneumococcal Conjugate Vaccine — Worldwide, 2000–2012
por: Wang, Susan A., et al.
Publicado: (2013)

All-Cause Pneumonia Hospitalizations in Children <2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction
por: Berglund, Anders, et al.
Publicado: (2014)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Prevention of Pneumonia
por: Loo, Jennifer D., et al.
Publicado: (2014)

Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
por: Whitney, Cynthia G., et al.
Publicado: (2014)

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
por: Rodgers, Gail L, et al.
Publicado: (2021)

Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean
por: Whitney, Cynthia G, et al.
Publicado: (2021)

Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries
por: de Oliveira, Lucia H, et al.
Publicado: (2020)

Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015)
por: Horácio, Andreia N., et al.
Publicado: (2018)

Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines
por: Sanneh, Bakary, et al.
Publicado: (2019)

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination
por: Shing, Jaimie Z., et al.
Publicado: (2019)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Tomczyk, Sara, et al.
Publicado: (2014)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006–2014
por: Izu, Alane, et al.
Publicado: (2017)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
por: Feikin, Daniel R., et al.
Publicado: (2013)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization
por: Loo, Jennifer D., et al.
Publicado: (2014)

Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022
por: Manzanal, Ayla, et al.
Publicado: (2023)

Why Do We Need a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules?
por: O’Brien, Katherine L., et al.
Publicado: (2014)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
por: Elemraid, Mohamed A., et al.
Publicado: (2013)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Bennett, Nancy M., et al.
Publicado: (2013)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Socioeconomic Disparities and Influenza Hospitalizations, Tennessee, USA
por: Sloan, Chantel, et al.
Publicado: (2015)

Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia
por: ELEMRAID, M. A., et al.
Publicado: (2013)

The Population Impact of a Large School-Based Influenza Vaccination Campaign
por: Grijalva, Carlos G., et al.
Publicado: (2010)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
por: Conklin, Laura, et al.
Publicado: (2014)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Methods for a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules
por: Loo, Jennifer D., et al.
Publicado: (2014)

Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil
por: Warren, Joshua L, et al.
Publicado: (2017)

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction
por: Conklin, Laura M., et al.
Publicado: (2016)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity
por: Deloria Knoll, Maria, et al.
Publicado: (2014)

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015
por: Kambiré, Dinanibè, et al.
Publicado: (2018)

Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children
por: Nair, Harish, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jdg7tje39btmjscenfkblthhdm